Currently out of the existing stock ratings of John Abbott, 7 are a BUY (41.18%), 6 are a HOLD (35.29%), 4 are a SELL (23.53%).

John Abbott

Work Performance Price Targets & Ratings Chart

Analyst John Abbott, currently employed at WOLFE, carries an average stock price target met ratio of 71.67% that have a potential upside of 16.72% achieved within 233 days. Previously, John Abbott worked at BAML.

John Abbott’s has documented 32 price targets and ratings displayed on 6 stocks. The coverage is on Healthcare, Energy sectors.

Most recent stock forecast was given on CRGY, Crescent Energy Co at 18-Jul-2024.

Wall Street Analyst John Abbott

Analyst best performing recommendations are on CNX (CNX RESOURCES CORP).
The best stock recommendation documented was for NOG (NORTHERN OIL & GAS) at 7/19/2022. The price target of $32 was fulfilled within 114 days with a profit of $9.78 (44.01%) receiving and performance score of 3.86.

Average potential price target upside

ARCT Arcturus Therapeutics Holdings CNX CNX Resources Corp NOG Northern Oil & Gas CRGY Crescent Energy Co CHRD Chord Energy Corp NFG National Fuel Gas Company

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$42

$19.44 (86.17%)

$45

1 months 25 days ago
(11-Aug-2025)

0/3 (0%)

$27.11 (182.07%)

Buy

$49

$26.44 (117.20%)

$47

1 months 25 days ago
(11-Aug-2025)

4/10 (40%)

$34.11 (229.08%)

195

Buy

$35

$12.44 (55.14%)

$32

3 months 5 days ago
(01-Jul-2025)

0/2 (0%)

$21.38 (156.98%)

Buy

$45

4 months 24 days ago
(12-May-2025)

0/5 (0%)

$35.65 (381.28%)

Buy

$60

5 months 27 days ago
(09-Apr-2025)

14/33 (42.42%)

$45.45 (312.37%)

165

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by John Abbott?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?